Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T4ADS testosterone gel crossover study in men with androgen deficiency-like symptoms
ACTRN12615000071527Phase 4Completed
- Sponsor
- Department of Andrology, Concord Repatriation General Hospital
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of AndroForte in Hypoandrogenism (TD) (3 arms), sponsored by Department of Andrology, Concord Repatriation General Hospital. Primary endpoint: Improvement in androgen deficiency-like symptoms with testosterone versus placebo. Started Feb 2016; status: completed.
02
Drugs
AndroForte
03
Conditions
Hypoandrogenism (TD)
Beyond the preview
Go deeper on ACTRN12615000071527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000071527.